Comparison of Survival Between Patients with Hepatocellular Carcinoma Beyond the “Up-to-7” Criterion Who Received Adjuvant PD-1 Inhibitors or Active Surveillance: A Target Trial Emulation Study
Jia-Yong Su, Zhen Liu, Tai-Xin Yang, Ping-Ping Guo, Min Luo, Shao-Ping Liu, Xiao-Feng Dong, Xiao-Ling Xu, Shu-Chang Chen, Jun-Jie Ou, Kang Chen, Zhi-Cheng Li, Ze Su, Fu-Quan Yang, Wen-Hai He, Ning Peng, Pei-Sheng Wu, Bei-Bei Long, Hang Su, Mei-Lan Huang, Wen-Ting Li, Wen-Ting Chen, Jian-Rong Li, Da-Long Yang, Zhi-Hao Huang, Lei-Po Lin, Rong-Rui Huo, Yi-Li Ma, Liang Ma, Xiao-Bin Zhong, Jian-Hong Zhong, on behalf of the GUIDANCE investigators